+45 33 75 10 00

info@nordic-labs.com

 

Description:

The Chlamydia Pneumoniae Elispot-LTT test is deisgned to detect the intracellular bacterium that causes many neurological and musculoskeletal diseases, including bronchitis and sinusitis.

 

Chlamydia is an intracellular bacterium, which causes many neurological and musculoskeletal diseases. There are 2 different sub-species of Chlamydia: Chlamydia pneumoniae and Chlamydia trachomatis. 

 

Chlamydia are a family of wide-branched, round-shaped bacteria, which—depending on their sub-groups—can cause various illnesses, from pneumonia to atherosclerosis, and possibly even heart attacks..  Chlamydia bacterium need cells of other organisms to survive and reproduce itself.

 

Chlamydia pneumoniae is widespread and can cause bronchial infections (bronchitis) and infections of the paranasal sinuses (sinusitis). It can cause lung infections (so called atypical pneumonia), which usually has a mild progression. Chlamydia pneumoniae can be found for example in following illnesses: Rheumatoid arthritis, Fibromyalgia, Multiple Sclerosis, Dementia, Parkinsonism, ALS, ADHS, ADS, Autism and many other diseases/syndromes.

 

Chlamydia pneumoniae infection in humans takes place mainly by small droplet transmission and has a very high degree of penetration. The Elispot-LTT for Chlamydia pneumoniae shows the actual T-cellular activity of the infection. This information makes it easier to diagnose Chlamydia infections and can also be used to check the success of a course of treatment.

 

Elispot-LTT tests:

The LTT test reflects the actual, current Borrelia burgdorferi activity of chronic and also acute Lyme infections. The Elispot-LTT is highly sensitive and can detect even one single Borrelia-reactive T-cell in the blood. The Elispot-LTT is very helpful when monitoring a chronic or acute Lyme therapy, and should usually become negative about 6 to 8 weeks after completion of an effective therapy.

Downloadable files